Also, the use of clozapine is indicated for the most severe (ie, treatment-resistant) cases of schizophrenia, which in turn is typically associated with poor lifestyle habits and more common risk factors for breast cancer, which could be expected to lead to an overestimation of the association between prolactin-sparing antipsychotics and breast cancer. The gene discussed is PRL; the disease is breast carcinoma.